The consensus molecular classification of muscle-invasive bladder cancer
Aurélie Kamoun(FIND), Katherine A. Hoadley(University of North Carolina at Chapel Hill), Alexandre R. Zlotta(University of Toronto), Hikmat Al‐Ahmadie(Unknown), Mattias Höglund(Lund University), Keith Syson Chan(Cedars-Sinai Medical Center), Núria Malats(Spanish National Cancer Research Centre), Jordan Kardos(University of North Carolina at Chapel Hill), Aurélien de Reyniès(La Ligue Contre le Cancer), Seth P. Lerner(Baylor College of Medicine), Peter C. Black(University of British Columbia), Lars Dyrskjøt(Aarhus University Hospital), David J. McConkey(Johns Hopkins University), Mauro A. A. Castro(Universidade Federal do Paraná), Francisco X. Real(Universitat Pompeu Fabra), Qianxing Mo(Memorial Sloan Kettering Cancer Center), Joaquim Bellmunt(Dana-Farber Cancer Institute), Gottfrid Sjödahl(Lund University), Jacqueline Fontugne(Centre National de la Recherche Scientifique), A. Gordon Robertson(Canada's Michael Smith Genome Sciences Centre), Roland Seiler(University of British Columbia), William Y. Kim(University of North Carolina at Chapel Hill), François Radvanyi(Centre National de la Recherche Scientifique), Thomas Powles(Queen Mary University of London), Pontus Eriksson(Lund University), Yves Allory(Institut Curie), Clarice S. Groeneveld(Universidade Federal do Paraná), Woonyoung Choi(The University of Texas MD Anderson Cancer Center), Colin P. Dinney(The University of Texas MD Anderson Cancer Center), Arndt Hartmann(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 153
Related Papers
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k